Group One Trading’s Akcea Therapeutics Inc AKCA Stock Holding History

Group One Trading’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-77,600	Closed	-$1.41M	–	7335
2020 Q3	$1.41M	Buy	77,600 +72,600	+1,452%	+$1.03M	﹤0.01%	1888
2020 Q2	$69K	Hold	5,000	–	–	﹤0.01%	4161
2020 Q1	$72K	Sell	5,000 -5,100	-50%	-$83.7K	﹤0.01%	3519
2019 Q4	$171K	Buy	10,100 +4,900	+94%	+$91.2K	﹤0.01%	3289
2019 Q3	$80K	Sell	5,200 -4,800	-48%	-$102K	﹤0.01%	3711
2019 Q2	$235K	Sell	10,000 -1,500	-13%	-$37.1K	﹤0.01%	2733
2019 Q1	$326K	Buy	11,500 +11,400	+11,400%	+$332K	﹤0.01%	2301
2018 Q4	$3K	Sell	100 -14,000	-99%	-$392K	﹤0.01%	4622
2018 Q3	$494K	Buy	14,100 +3,600	+34%	+$109K	﹤0.01%	2292
2018 Q2	$249K	Buy	10,500 +6,900	+192%	+$165K	﹤0.01%	2887
2018 Q1	$92K	Buy	+3,600	New	+$77.5K	﹤0.01%	3301

Group One Trading's AKCA Position: Q4 2020 in Review

Group One Trading sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 12,800 shares — an estimated $232K sold.

Group One Trading first reported a position in AKCA in Q2 2019 and held it in 6 quarters. The position peaked at $234K in Q2 2019. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Group One Trading reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Group One Trading sold 12,800 Akcea Therapeutics Inc shares in Q4 2020, an estimated $232K.
Group One Trading first reported a position in Akcea Therapeutics Inc in Q2 2019 and held it in 6 quarters.
Group One Trading's Akcea Therapeutics Inc position peaked at $234K in Q2 2019.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Group One Trading's 13F filing for Q4 2020, filed 10 Feb 2021.